ProfileGDS4718 / 242770_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 53% 51% 61% 71% 73% 62% 81% 67% 66% 32% 65% 69% 74% 69% 71% 69% 71% 81% 78% 54% 74% 78% 65% 74% 84% 40% 71% 44% 76% 73% 78% 74% 85% 84% 76% 75% 62% 68% 72% 76% 72% 69% 55% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.657853
GSM549102patient 115, normal, homogenized [OPG study]5.5882551
GSM549104patient 119, normal, homogenized [OPG study]6.1992761
GSM549108patient 138, normal, homogenized [OPG study]6.952371
GSM549119patient 077, normal, homogenized [OPG study]7.0694473
GSM549133patient 032, cancer, homogenized [OPG study]6.2352462
GSM549139patient 042, cancer, homogenized [OPG study]7.9546481
GSM549099patient 107, normal, homogenized [OPG study]6.6184667
GSM549109patient 139, normal, homogenized [OPG study]6.5665466
GSM549110patient 046, normal, homogenized [OPG study]4.6411332
GSM549114patient 063, normal, homogenized [OPG study]6.4125465
GSM549122patient 082, normal, homogenized [OPG study]6.8313169
GSM549134patient 033, cancer, homogenized [OPG study]7.200274
GSM549136patient 036, cancer, homogenized [OPG study]6.7902669
GSM549140patient 044, cancer, homogenized [OPG study]7.0348771
GSM549111patient 047, normal, homogenized [OPG study]6.8454169
GSM549113patient 057, normal, homogenized [OPG study]6.9535171
GSM549132patient 031, cancer, homogenized [OPG study]7.953781
GSM549137patient 038, cancer, homogenized [OPG study]7.6873978
GSM549142patient 047, cancer, homogenized [OPG study]5.874454
GSM549100patient 110, normal, homogenized [OPG study]7.190174
GSM549107patient 135, normal, homogenized [OPG study]7.6857378
GSM549115patient 068, normal, homogenized [OPG study]6.4443265
GSM549116patient 072, normal, homogenized [OPG study]7.2249674
GSM549120patient 078, normal, homogenized [OPG study]8.2822284
GSM549131patient 030, cancer, homogenized [OPG study]4.9162440
GSM549118patient 074, normal, homogenized [OPG study]6.9342771
GSM549129patient 027, cancer, homogenized [OPG study]5.2282344
GSM549123patient 088, normal, homogenized [OPG study]7.4132876
GSM549124patient 006, cancer, homogenized [OPG study]7.1035773
GSM549126patient 015, cancer, homogenized [OPG study]7.6340578
GSM549128patient 025, cancer, homogenized [OPG study]7.3508874
GSM549103patient 117, normal, homogenized [OPG study]8.3662985
GSM549117patient 073, normal, homogenized [OPG study]8.3705584
GSM549138patient 041, cancer, homogenized [OPG study]7.4304576
GSM549141patient 045, cancer, homogenized [OPG study]7.4104875
GSM549130patient 028, cancer, homogenized [OPG study]6.2841562
GSM549101patient 111, normal, homogenized [OPG study]6.7131868
GSM549105patient 128, normal, homogenized [OPG study]6.9944472
GSM549106patient 134, normal, homogenized [OPG study]7.6207676
GSM549112patient 048, normal, homogenized [OPG study]7.0084472
GSM549125patient 011, cancer, homogenized [OPG study]6.8030869
GSM549127patient 024, cancer, homogenized [OPG study]5.839555
GSM549135patient 035, cancer, homogenized [OPG study]6.9291570